2
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
34
Ovarian Neoplasms
31
Peritoneal Neoplasms
28
Fallopian Tube Neoplasms
14
Colorectal Neoplasms
14
Carcinoma, Ovarian Epithelial
13
Appendiceal Neoplasms
7
Neoplasm Metastasis
5
Pancreatic Neoplasms
4
Uterine Neoplasms
3
Recurrence
3
Pseudomyxoma Peritonei
3
Neoplasms
3
Carcinoma
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Peritoneal Diseases
2
Mesothelioma, Malignant
2
Mesothelioma
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gastrointestinal Neoplasms
2
Gastric Adenocarcinoma
2
Desmoplastic Small Round Cell Tumor
2
Colonic Neoplasms
2
Wilms Tumor
1
Stomach Diseases
1
Stage â…¢ Gastric Cancer
1
Stage IV Gastric Cancer With Metastasis
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Interventions
Vincristine
25
Cyclophosphamide
25
Irinotecan
21
Temozolomide
18
Doxorubicin
16
Radiotherapy
15
Filgrastim
15
Ifosfamide
14
Dactinomycin
14
Etoposide
11
Vinorelbine
9
Melphalan
9
Magnetic Resonance Spectroscopy
9
Granulocyte Colony-Stimulating Factor
9
Radiation
8
pegfilgrastim
7
X-Rays
7
Specimen Handling
7
Sirolimus
7
Topotecan
6
Phantoms, Imaging
6
Peripheral Blood Stem Cell Transplantation
6
Gemcitabine
6
cixutumumab
5
Busulfan
5
Biopsy
5
temsirolimus
4
irinotecan sucrosofate
4
fludarabine
4
etoposide phosphate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled